Suchthilfe Wien gGmbH

Opioid Dependence Treatment

Clinical research at Suchthilfe Wien gGmbH is centered on opioid dependence and the management of severe, chronic substance use disorders in a clinical care setting in Vienna.

  • Opioid agonist therapy
  • Hydromorphone-based treatment
  • Intravenous opioid treatment

The sponsor’s research interest includes improving access to care for patients with unmet treatment needs and extending services to groups that are insufficiently reached by existing approaches.

Clinical Integration of Addiction Care

Another focus is the practical integration of intravenous opioid agonist therapy into routine clinical practice, with attention to feasibility and acceptance among both patients and staff.

  • Feasibility in routine care
  • Staff and patient acceptance
  • Service implementation

This area reflects interest in establishing treatment models within an addiction-care facility rather than in a general research environment.

Somatic and Psychological Health

The sponsor’s research landscape also includes the stabilization of overall health in people living with opioid dependence, covering both physical health and mental health dimensions.

  • Somatic health
  • Psychological wellbeing
  • Clinical stabilization

These interests align with care for complex addiction-related conditions where medical and psychiatric needs overlap.

Social and Behavioral Outcomes

Research activity also addresses social functioning and behavior in the context of opioid use, including changes in social stability, delinquency, and treatment retention.

  • Treatment retention
  • Social situation stabilization
  • Reduction in delinquency

These topics place the sponsor’s work at the intersection of addiction medicine, social care, and patient engagement.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on the Safety and Feasibility of Intravenous Hydromorphone Hydrochloride for Patients with Opioid Dependence

    Not recruiting

    1 1 1
    Investigated drugs:
    Austria